385 BioNTech says in its annual report to the US Securities and Exchange Commission that the efficacy of its current mRNA Corona vaccine may not be sufficient for permanent regulatory approval. (media.greatawakening.win) posted 2 years ago by purkiss80 2 years ago by purkiss80 +386 / -1 27 comments download share 27 comments share download save hide report block hide replies
Any organisation that is created to regulate something powerful, you can bet on it being set up to protect certain elements within the area of purview.